Page last updated: 2024-12-07

beta-hydroxyvaleric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Beta-hydroxyvaleric acid (BHVA) is a naturally occurring hydroxycarboxylic acid found in various biological systems. It has been reported to exhibit several interesting properties, including anti-inflammatory and antioxidant effects. BHVA can be synthesized through various methods, including enzymatic reactions and chemical synthesis. Researchers are investigating its potential applications in areas such as medicine, cosmetics, and food additives. Its anti-inflammatory properties are attributed to its ability to inhibit the production of pro-inflammatory cytokines, while its antioxidant activity stems from its ability to scavenge free radicals. Ongoing studies are focusing on exploring the mechanisms underlying these effects and evaluating BHVA's safety and efficacy for therapeutic purposes.'

3-hydroxypentanoic acid : A short-chain fatty acid that is valeric acid in which one of the methylene hydrogens at position 3 has been replaced by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID107802
CHEBI ID139272
CHEBI ID89628
SCHEMBL ID27643
MeSH IDM0060506

Synonyms (44)

Synonym
LMFA01050008
3-hydroxy valeric acid
3-ethyl hydroxy acrylic acid
3-hydroxy-pentanoic acid
beta-hydroxyvaleric acid
3-hydroxyvaleric acid
3-hydroxypentanoic acid
CHEBI:139272
10237-77-1
unii-9d6k40j6uz
9d6k40j6uz ,
AKOS011682998
SCHEMBL27643
REKYPYSUBKSCAT-UHFFFAOYSA-N
AM85451
pentanoicacid,3-hydroxy-
pentanoic acid, 3-hydroxy-
mfcd07778468
CHEBI:89628
C14017
b-hydroxy-n-valerate
b-hydroxy-n-valeric acid
3-hydroxy-valerate
3-hydroxy-valeric acid
3-hydroxy-n-valerate
beta-hydroxy-n-valeric acid
b-hydroxyvaleric acid
3-hydroxy-n-valeric acid
beta-hydroxy-n-valerate
b-hydroxyvalerate
CS-0059321
HY-113004
beta-hydroxyvalerate
DTXSID00864240
(rs)-3-hydroxyvaleric acid
Q2823214
3-hydroxypentanoicacid
BS-14272
.beta.-hydroxyvaleric acid
(+/-)-3-hydroxypentanoic acid
A929364
rac-3-hydroxypentanoic acid
EN300-224741
PD102041

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"Here, we report an analysis method for determining PHA (polyhydroxyalkanoates) contents and their monomer composition in microbial cells based on pyrolysis gas chromatography combined with mass spectrometry (Py-GC/MS)."( Rapid analysis of polyhydroxyalkanoate contents and its monomer compositions by pyrolysis-gas chromatography combined with mass spectrometry (Py-GC/MS).
Jeon, SG; Khang, TU; Kim, MJ; Na, JG; Park, SJ; Sohn, YJ; Yoo, JI, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
short-chain fatty acidAn aliphatic monocarboxylic acid with a chain length of less than C6. If any non-hydrocarbon substituent is present, the compound is not normally regarded as a short-chain fatty acid.
3-hydroxy fatty acidAny fatty acid with a hydroxy functional group in the beta- or 3-position. beta-Hydroxy fatty acids accumulate during cardiac hypoxia, and can also be used as chemical markers of bacterial endotoxins.
ketone bodyA carbonyl compound produced as a water-soluble byproduct when fatty acids are broken down for energy in the liver. There are three endogenous ketone bodies: acetone, acetoacetic acid, and (R)-3-hydroxybutyric acid; others may be produced as a result of the metabolism of synthetic triglycerides.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (121)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.83)18.7374
1990's12 (9.92)18.2507
2000's18 (14.88)29.6817
2010's57 (47.11)24.3611
2020's33 (27.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.97 (24.57)
Research Supply Index4.84 (2.92)
Research Growth Index5.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.79%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other125 (99.21%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]